HealthPhoto: Amar UjalaCorbevax Vaccine Updated Against New Covid Variant JN.1
The Corbevax vaccine will be updated to protect against the new Covid JN.1 variant. The CDSCO expert committee approved changes to the vaccine developed by Biological-E, based on studies involving 280 people aged 18 to 80. The committee set conditions including submission of safety data, monitoring adverse effects, providing separate information leaflets for healthcare workers and recipients, and recording vaccinations on CoWIN or U-WIN platforms.
Amar Ujala·




